Exploratory biomarker analysis from a phase II, multicenter, randomized trial of eribulin plus gemcitabine(EG) versus paclitaxel plus gemcitabine(PG) as first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer(MBC): Korean cancer study group trial (KCSG BR13-11)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, JY[Kim, J-Y] | - |
dc.contributor.author | Lee, EJ[Lee, E. J.] | - |
dc.contributor.author | Park, KH[Park, K. H.] | - |
dc.contributor.author | Im, SA[Im, S-A] | - |
dc.contributor.author | Kim, SB[Kim, S-B] | - |
dc.contributor.author | Sohn, SH[Sohn, S. H.] | - |
dc.contributor.author | Lee, KS[Lee, K. S.] | - |
dc.contributor.author | Chae, YS[Chae, Y. S.] | - |
dc.contributor.author | Lee, KH[Lee, K. H.] | - |
dc.contributor.author | Kim, JH[Kim, J. H.] | - |
dc.contributor.author | Im, YH[Im, Y-H] | - |
dc.contributor.author | Kim, TY[Kim, T-Y] | - |
dc.contributor.author | Lee, KH[Lee, K-H] | - |
dc.contributor.author | Ahn, JH[Ahn, J-H] | - |
dc.contributor.author | Kim, GM[Kim, G. M.] | - |
dc.contributor.author | Park, IH[Park, I. H.] | - |
dc.contributor.author | Lee, SJ[Lee, S. J.] | - |
dc.contributor.author | Han, HS[Han, H. S.] | - |
dc.contributor.author | Kim, SH[Kim, S. H.] | - |
dc.contributor.author | Jung, KH[Jung, K. H.] | - |
dc.contributor.author | Park, YH[Park, Y. H.] | - |
dc.date.accessioned | 2021-07-28T20:45:39Z | - |
dc.date.available | 2021-07-28T20:45:39Z | - |
dc.date.created | 2019-11-28 | - |
dc.date.issued | 2019-02 | - |
dc.identifier.issn | 0008-5472 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/11016 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC CANCER RESEARCH | - |
dc.title | Exploratory biomarker analysis from a phase II, multicenter, randomized trial of eribulin plus gemcitabine(EG) versus paclitaxel plus gemcitabine(PG) as first-line chemotherapy for human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer(MBC): Korean cancer study group trial (KCSG BR13-11) | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, JY[Kim, J-Y] | - |
dc.contributor.affiliatedAuthor | Im, YH[Im, Y-H] | - |
dc.contributor.affiliatedAuthor | Park, YH[Park, Y. H.] | - |
dc.identifier.doi | 10.1158/1538-7445.SABCS18-P3-11-07 | - |
dc.identifier.wosid | 000478677001222 | - |
dc.identifier.bibliographicCitation | CANCER RESEARCH, v.79, no.4 | - |
dc.relation.isPartOf | CANCER RESEARCH | - |
dc.citation.title | CANCER RESEARCH | - |
dc.citation.volume | 79 | - |
dc.citation.number | 4 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.